(Reuters) – Sun Pharmaceutical Industries Limited said on Thursday it will acquire U.S.-based Concert Pharmaceuticals through a tender offer for an upfront payment of $8 per share in cash.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shinjini Ganguli)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.